The presence of AD pathology was another predictor of worse than expected cognitive decline given the degree of brain atrophy, as presence of an APOEe4 allele, as well as amyloid and tau pathology were associated with the residual measure in bivariate analyses, and amyloid pathology also in multivariate analysis. This evidence concerns the gene MAPT and amyloidosis.